Cancel
Ansa Biotechnologies
See Linkedin
Ansa Biotechnologies Employees
11 people indexed:
-
77g@3qejhwh.tzv Sign up to see email
-
y1djfq@7w2hk7w.7wu Sign up to see email
-
v04lt@0h56132.9qv Sign up to see email
-
pf695@utxpk2x.qy3 Sign up to see email
-
Jeremiah Hanes
Senior Vice President, Research and Development
txy18451@1t00wk4.w7k Sign up to see email8fg8t5xp@zwk8ggu.vzk Sign up to see email -
r6d8lwu@0zh1hgq.ru6 Sign up to see email
-
ku4p@6dg4l61.wft Sign up to see email
-
024pg5@juvzetj.ldg Sign up to see email
-
fuwf@xf3tq08.1tu Sign up to see email
-
wxzg1x6l8@j4yr1kf.w7h Sign up to see email
-
3tdl@2q761jj.94f Sign up to see email
Ansa Biotechnologies Company Information
Ansa Biotechnologies is located in Emeryville, California, and operates within the healthcare sector, specifically in the industrial bio sub-industry. As a participant in the Y Combinator W20 batch, Ansa has developed a reputation for its innovative approach to DNA synthesis, utilizing an enzyme-based method that promises faster, cleaner, and more accurate results compared to traditional methods. The company has a team of 72 employees and has recently secured $68 million in Series A financing to further develop its technology platform, expand research and development, and enhance manufacturing capabilities.
Ansa Biotechnologies is committed to accelerating innovation in various fields including therapeutics, diagnostics, and biomanufacturing through its advanced DNA synthesis technology. The company offers an Early Access Program that allows researchers to explore its services, particularly focusing on synthesizing complex sequences such as GC- or AT-rich sequences, sequences that form secondary structures, and repetitive sequences. Ansa’s technology has already seen practical application, as demonstrated by their successful synthesis and delivery of challenging promoter sequences to their first Early Access customer, Enoda. Additionally, Ansa has made its presence known at significant industry events like the Global Synthetic Biology Conference, showcasing their cutting-edge enzymatic DNA synthesis technology.
Report inaccurate information
Report inaccurate information